ImmBio is a vaccine company developing vaccine systems. The portfolio addresses areas of high unmet need, where the risk and consequence of infection are severe.
Company (Alive / Active)
|Investor||Investor Type||Location||Participating Rounds|
|Cranbury, New Jersey, United States||Dead / Inactive||VaxInnate is a privately-held biotechnology company in Cranbury, NJ that is developing a technology platform for use in developing novel and proprietary vaccines. VaxInnate's vaccines focus on infectious diseases, including seasonal and pandemic flu, dengue, and Clostridium difficile. VaxInnate's technology has the potential to dramatically improve the potency, manufacturing capacity and cost-effectiveness of vaccines. VaxInnate has already generated positive Phase 1, and in some instances Phase...Show all||Login to see details|
|Italy||Alive / Active||nnFor more than fifty years, the company have been plotting the route in Allergy medicine. The company have been leading generations of allergists to some of the most discoveries in this science:na vaccine by bronchial route, a vaccine by nasal route, the Methacholine Challenge Test, the Test Dose for foodstuff or additives allergy, and allergens adsorbed on single-use needles.||Login to see details|